Filters

Bcl-2 beta Antibody

Bcl-2 beta Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameBcl-2 beta Primary Polyclonal Antibody
Also known asBcl-2 beta PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenBcl-2 beta
SpecificityThis is a highly specific antibody against Bcl-2 beta
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human apoptosis regulator Bcl-2 beta isoform
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivityHuman
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Constitutive expression of BCL2, Jul 2008], Two transcript variants, [provided by RefSeq, differ in their C-terminal ends, is thought to be the cause of follicular lymphoma, produced by alternate splicing, such as in the case of translocation of BCL2 to Ig heavy chain locus, This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names apoptosis regulator Bcl-2, apoptosis regulator Bcl-2 beta isoform, protein phosphatase 1, regulatory subunit 50, bcl2-beta protein
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetBcl-2 beta
Short nameBcl-2 beta Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameBcl-2 b (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter